Unknown

Dataset Information

0

The structure of NS-398 bound to cyclooxygenase-2.


ABSTRACT: The cyclooxygenases (COX-1 and COX-2) are membrane-associated, heme-containing homodimers that generate prostaglandin H(2) from arachidonic acid (AA) in the committed step of prostaglandin biogenesis and are the targets for nonsteroidal anti-inflammatory drugs (NSAIDs). N-(2-cyclohexyloxy-4-nitrophenyl) methanesulfonamide (NS-398) was the first in a series of isoform-selective drugs designed to preferentially inhibit COX-2, with the aim of ameliorating many of the toxic gastrointestinal side effects caused by conventional NSAID inhibition. We determined the X-ray crystal structure of murine COX-2 in complex with NS-398 utilizing synchrotron radiation to 3.0A resolution. NS-398 binds in the cyclooxygenase channel in a conformation that is different than that observed for other COX-2-selective inhibitors, such as celecoxib, with no discernible penetration into the side pocket formed in COX-2 by the isoform-specific substitutions of I434V, H513R, and I523V. Instead, the methanesulfonamide moiety of NS-398 interacts with the side chain of Arg-120 at the opening of the cyclooxygenase channel, similar to that observed for acidic, nonselective NSAIDs such as indomethacin and flurbiprofen. Our structure validates inhibitor studies that identified Arg-120 as a molecular determinant for time-dependent inhibition of COX-2 by NS-398.

SUBMITTER: Vecchio AJ 

PROVIDER: S-EPMC3185125 | biostudies-literature | 2011 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

The structure of NS-398 bound to cyclooxygenase-2.

Vecchio Alex J AJ   Malkowski Michael G MG  

Journal of structural biology 20110806 2


The cyclooxygenases (COX-1 and COX-2) are membrane-associated, heme-containing homodimers that generate prostaglandin H(2) from arachidonic acid (AA) in the committed step of prostaglandin biogenesis and are the targets for nonsteroidal anti-inflammatory drugs (NSAIDs). N-(2-cyclohexyloxy-4-nitrophenyl) methanesulfonamide (NS-398) was the first in a series of isoform-selective drugs designed to preferentially inhibit COX-2, with the aim of ameliorating many of the toxic gastrointestinal side eff  ...[more]

Similar Datasets

| S-EPMC2861287 | biostudies-literature
| S-EPMC4276492 | biostudies-literature
| S-EPMC5053162 | biostudies-literature
| S-EPMC4711821 | biostudies-literature
| S-EPMC9271712 | biostudies-literature
| S-EPMC3023485 | biostudies-literature
| S-EPMC1950011 | biostudies-other
| S-EPMC7900114 | biostudies-literature
| S-EPMC3918146 | biostudies-literature
| S-EPMC3918835 | biostudies-literature